- Why do HIV pre-exposure prophylaxis users discontinue pre-exposure prophylaxis care? A mixed methods survey in a pre-exposure prophylaxis clinic in Belgium(2022)
Auteurs: Thibaut Vanbaelen, Anke Rotsaert, Bart Jacobs, Eric Florence, Christopher Kenyon, Bea Vuylsteke, Marie Laga, Thijs Reyniers
Pagina's: 159-167
Aantal pagina's: 9
- A public health value-based healthcare paradigm for HIV(2022)
Auteurs: Sebastian Vermeersch, Rémy P Demeester, Nathalie Ausselet, Steven Callens, Paul De Munter, Eric Florence, Jean-Christophe Goffard, Sophie Henrard, Patrick Lacor, Peter Messiaen, et al.
Pagina's: 1-11
Aantal pagina's: 11
- Incidence and risk factors for suicide, violent/accidental deaths, and substance abuse deaths in persons living with HIV(2021)
Auteurs: E. Tusch, L. Peters, O. Fursa, L. Ryom, L. Oestergaard, Eric Florence, S. Edwards, Christopher J Hoffmann, H Sambatakou, P. Reiss, et al.
Pagina's: 236-237
Aantal pagina's: 2
- Screening for STIs is one of the main drivers of macrolide consumption in PrEP users(2021)
Auteurs: Thibaut Vanbaelen, Christophe Van Dijck, Irith De Baetselier, Eric Florence, Thijs Reyniers, Bea Vuylsteke, Bart Jacobs, Christopher Kenyon
Pagina's: 1183-1184
Aantal pagina's: 2
- The impact of physical restriction measures imposed during the two waves of COVID-19 on chlamydia and gonorrhea diagnoses in Belgium: results of an sexually transmitted infection clinic(2021)
Auteurs: Irith De Baetselier, L Apers, Tom Platteau, Jozefien Buyze, Eric Florence, Christopher Kenyon, Dorien Van Den Bossche
Pagina's: 998-1003
Aantal pagina's: 6
- Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL): examining health care staff attitudes during a hybrid III implementation-effectiveness trial implementing cabotegravir plus rilpivirine long-acting injectable (CAB plus RPV LA) for people living with HIV (PLHIV)(2021)
Auteurs: C. Gutner, S. Dakhia, Mandev S. Gill, M. Pascual-Bernaldez, Brenda Y. Hernandez, A. Rami, J. Portilla, T. Lutz, Marc van der Valk, Eric Florence, et al.
Pagina's: 114-115
Aantal pagina's: 2
- The hepatitis C cascade of care in the Belgian HIV population: one step closer to elimination(2021)
Auteurs: Dana Busschots, Cécile Kremer, Özgür M Koc, Leen Heyens, Rob Bielen, L Apers, Eric Florence, Peter Messiaen, Kristel Van Laethem, Eric Van Wijngaerden, et al.
Pagina's: 217-223
Aantal pagina's: 7
- Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV(2021)
Auteurs: Ana González-Cordón, Lambert Assoumou, Graeme Moyle, Laura Waters, Margaret Johnson, Pere Domingo, Julie Fox, Hans-Jürgen Stellbrink, Giovanni Guaraldi, Mar Masia, et al.
Pagina's: 2380-2393
Aantal pagina's: 14
- Did pre-exposure prophylaxis roll-out influence the epidemic of rectal lymphogranuloma venereum in Belgium? Results from the national surveillance system(2021)
Auteurs: Irith De Baetselier, Achilleas Tsoumanis, Eric Florence, Wim Vanden Berghe, Tania Crucitti, D. Van den Bossche, Christopher Kenyon
Pagina's: e1-e5
Aantal pagina's: 5
- Quality of life in people living with HIV: an exploratory cross-sectional survey in Belgium(2021)
Auteurs: Gert Scheerder, Sandra Van den Eynde, Patrick Reyntiens, Ria Koeck, Jessika Deblonde, Charles Ddungu, Eric Florence, Christina Joosten, Eric Van Wijngaerden, Alexis Dewaele
Pagina's: 249-264
Aantal pagina's: 16